Margaretta Page
- Genetics top 1%
- Glioma Diagnosis and Treatment 16
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 2
-
- Brain Metastases and Treatment 7
- Cancer-related cognitive impairment studies 2
- Neurology top 10%
-
- Cancer survivorship and care 6
- Cancer Treatment and Pharmacology 2
-
- Palliative Care and End-of-Life Issues 6
-
- Childhood Cancer Survivors' Quality of Life 4
- Co-authors
- Susan M. ChangJane RabbittMichael D. PradosKathleen R. LambornRaymond LiuKarla SolheimMary MalecSherry Fox
- Journals
- Journal of Clinical Oncology (4 papers)Cancer (1 paper)International Journal of Radiation Oncology*Biology*Physics (4 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Margaretta Page
23 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 83
- Genetics 778
- Cancer Research 205
- Pulmonary and Respiratory Medicine 419
- Neurology 141
- Oncology 221
Countries citing papers authored by Margaretta Page
This map shows the geographic impact of Margaretta Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaretta Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaretta Page more than expected).
Fields of papers citing papers by Margaretta Page
This network shows the impact of papers produced by Margaretta Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaretta Page. The network helps show where Margaretta Page may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Margaretta Page, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 6 | |
| 2 | 2020 | 1 | |
| 3 | 2018 | 33 | |
| 4 | 2018 | 1 | |
| 5 | 2018 | 1 | |
| 6 | 2013 | 34 | |
| 7 | 2011 | 33 | |
| 8 | 2010 | 0 | |
| 9 | 2008 | 60 | |
| 10 | 2008 | 175 | |
| 11 | Phase I/pharmacokinetic study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma | 2007 | 1 |
| 12 | 2005 | 46 | |
| 13 | 2004 | 117 | |
| 14 | 2004 | 67 | |
| 15 | 2003 | 45 | |
| 16 | 2001 | 108 | |
| 17 | 1999 | 52 | |
| 18 | 1998 | 33 | |
| 19 | 1996 | 40 | |
| 20 | Health care system, cancer registration and follow-up of cancer patients in the United Kingdom. | 1995 | 1 |
About Margaretta Page
Margaretta Page is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (16 papers), Brain Metastases and Treatment (7 papers), Cancer survivorship and care (6 papers), Palliative Care and End-of-Life Issues (6 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer-related cognitive impairment studies (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Genetics (778 citations), Cancer Research (205 citations) and Pulmonary and Respiratory Medicine (419 citations). Margaretta Page has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Susan M. Chang, Jane Rabbitt, Michael D. Prados, Kathleen R. Lamborn, Raymond Liu, Karla Solheim, Mary Malec, Sherry Fox, Penny K. Sneed and William M. Wara. Their work appears in journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.